WO2011124895A3 - Phospholipid-containing pharmaceutical and nutraceutical compositions - Google Patents
Phospholipid-containing pharmaceutical and nutraceutical compositions Download PDFInfo
- Publication number
- WO2011124895A3 WO2011124895A3 PCT/GB2011/000548 GB2011000548W WO2011124895A3 WO 2011124895 A3 WO2011124895 A3 WO 2011124895A3 GB 2011000548 W GB2011000548 W GB 2011000548W WO 2011124895 A3 WO2011124895 A3 WO 2011124895A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- phospholipid
- containing pharmaceutical
- nutraceutical compositions
- physiologically tolerable
- lipophilic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
This invention provides a pharmaceutical composition comprising a physiologically tolerable phospholipid selected from the group consisting of marine phospholipids and lecithin and said physiologically tolerable phospholipid having dispersed therein a physiologically tolerable, lipophilic, structure disrupting agent phospholipid having lipophilic, structure disrupting agent.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1006012.7A GB201006012D0 (en) | 2010-04-09 | 2010-04-09 | Composition |
GB1006012.7 | 2010-04-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011124895A2 WO2011124895A2 (en) | 2011-10-13 |
WO2011124895A3 true WO2011124895A3 (en) | 2012-11-22 |
Family
ID=42236133
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2011/000548 WO2011124895A2 (en) | 2010-04-09 | 2011-04-08 | Phospholipid-containing pharmaceutical and nutraceutical compositions |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201006012D0 (en) |
WO (1) | WO2011124895A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY39010A (en) * | 2020-01-10 | 2021-08-31 | Monsanto Technology Llc | AUXIN HERBICIDE COMPOSITIONS INCLUDING DRIFT RETARDING AGENTS AND METHODS OF PREPARING THEM |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2194842A (en) * | 1936-02-25 | 1940-03-26 | American Lecithin Co | Soft lecithin preparation |
US2494771A (en) * | 1947-01-30 | 1950-01-17 | Cargill Inc | Phosphatide composition and shortening and methods for making same |
US2555972A (en) * | 1948-03-27 | 1951-06-05 | Central Soya Co | Preparation of phosphatides |
US4842865A (en) * | 1986-04-24 | 1989-06-27 | A. Nattermann & Cie Gmbh | Use of glycofurol for the liquidization of pharmaceutical preparations to be filled into soft gelatine capsules |
GB2282586A (en) * | 1993-09-28 | 1995-04-12 | Scherer Gmbh R P | Soft gelatin capsule manufacture |
US5536729A (en) * | 1993-09-30 | 1996-07-16 | American Home Products Corporation | Rapamycin formulations for oral administration |
WO2002056709A1 (en) * | 2001-01-17 | 2002-07-25 | R.P. Scherer Technologies, Inc. | Ingestible compositions containing an odoriferous oil |
WO2003009704A2 (en) * | 2001-07-27 | 2003-02-06 | N.V. Nutricia | Enteral compositions for the prevention and/or treatment of sepsis |
FR2880538A1 (en) * | 2005-01-07 | 2006-07-14 | Polaris Soc Par Actions Simpli | Composition, useful in an anti-inflammatory and moisturizing for skin, comprises fish oil and phospholipids |
WO2008117062A1 (en) * | 2007-03-28 | 2008-10-02 | Aker Biomarine Asa | Bioeffective krill oil compositions |
WO2010097701A1 (en) * | 2009-02-26 | 2010-09-02 | Aker Biomarine Asa | Low viscosity phospholipid compositions |
-
2010
- 2010-04-09 GB GBGB1006012.7A patent/GB201006012D0/en not_active Ceased
-
2011
- 2011-04-08 WO PCT/GB2011/000548 patent/WO2011124895A2/en active Application Filing
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2194842A (en) * | 1936-02-25 | 1940-03-26 | American Lecithin Co | Soft lecithin preparation |
US2494771A (en) * | 1947-01-30 | 1950-01-17 | Cargill Inc | Phosphatide composition and shortening and methods for making same |
US2555972A (en) * | 1948-03-27 | 1951-06-05 | Central Soya Co | Preparation of phosphatides |
US4842865A (en) * | 1986-04-24 | 1989-06-27 | A. Nattermann & Cie Gmbh | Use of glycofurol for the liquidization of pharmaceutical preparations to be filled into soft gelatine capsules |
GB2282586A (en) * | 1993-09-28 | 1995-04-12 | Scherer Gmbh R P | Soft gelatin capsule manufacture |
US5536729A (en) * | 1993-09-30 | 1996-07-16 | American Home Products Corporation | Rapamycin formulations for oral administration |
WO2002056709A1 (en) * | 2001-01-17 | 2002-07-25 | R.P. Scherer Technologies, Inc. | Ingestible compositions containing an odoriferous oil |
WO2003009704A2 (en) * | 2001-07-27 | 2003-02-06 | N.V. Nutricia | Enteral compositions for the prevention and/or treatment of sepsis |
FR2880538A1 (en) * | 2005-01-07 | 2006-07-14 | Polaris Soc Par Actions Simpli | Composition, useful in an anti-inflammatory and moisturizing for skin, comprises fish oil and phospholipids |
WO2008117062A1 (en) * | 2007-03-28 | 2008-10-02 | Aker Biomarine Asa | Bioeffective krill oil compositions |
WO2010097701A1 (en) * | 2009-02-26 | 2010-09-02 | Aker Biomarine Asa | Low viscosity phospholipid compositions |
Non-Patent Citations (1)
Title |
---|
DR. POEHLMANN & CO. GMBH: "Voltax Kapseln", 1 March 2002 (2002-03-01), XP002681796, Retrieved from the Internet <URL:http://www.dr-poehlmann.de/pdf/gi_voltax_kapseln.pdf> [retrieved on 20120814] * |
Also Published As
Publication number | Publication date |
---|---|
WO2011124895A2 (en) | 2011-10-13 |
GB201006012D0 (en) | 2010-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011128630A3 (en) | Anti-abuse gelled pharmaceutical compositions | |
WO2011115684A3 (en) | Lipid vesicle compositions and methods of use | |
WO2007101551A3 (en) | Phospholipid complexes of curcumin having improved bioavailability | |
WO2011153493A3 (en) | Biodegradable lipids for the delivery of active agents | |
WO2010019239A3 (en) | Pharmaceutical composition of n- [2,4-bis (1, 1 -dimethylethyl) - 5 - hydroxyphenyl] - 1, 4 - dihydro - 4 - oxoquinoline - 3 - carboxamide and administration thereof | |
WO2009121039A3 (en) | Administration of benzodiazepine compositions | |
WO2012174158A3 (en) | Administration of benzodiazepine | |
MX2012001939A (en) | Pharmaceutical composition and administrations thereof. | |
MX2009010372A (en) | Novel composition based on cholest-4-ene-3-one oxime. | |
MX2011010835A (en) | Sublingual pharmaceutical composition comprising a neutral oil. | |
WO2012009723A8 (en) | C-met modulator pharmaceutical compositions | |
TN2012000392A1 (en) | Oral formulations and lipophilic salts of methylnaltrexone | |
IL222578A0 (en) | Method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and the compositions comprising same | |
WO2011128627A8 (en) | Oral veterinary pharmaceutical and nutraceutical compositions | |
MX2014002362A (en) | Formulations and dosage forms of oxidized phospholipids. | |
WO2009018338A3 (en) | Phosphorylated pyrone analogs and methods | |
WO2016040887A3 (en) | Multilamellar lipid vesicle compositions and methods of use | |
WO2013134534A3 (en) | Solid state forms of cabazitaxel and processes for preparation thereof | |
WO2012119781A3 (en) | Novel lipids, phospholipids, phospholipid and lipid compositions and their use | |
EP2723345A4 (en) | Composition comprising phosphatidylcholine as an active ingredient for attenuating toxicity of anticancer agent | |
TN2009000510A1 (en) | Extended release formulation of nevirapine | |
EP2586449A4 (en) | Lipid emulsion having krill oil as an active ingredient and preparation method therefor | |
WO2013170086A3 (en) | Formulations for the delivery of active ingredients | |
WO2011009851A3 (en) | Walnut extracts for nutraceutical applications | |
WO2012080176A3 (en) | Pharmaceutical compositions comprising alisporivir |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11715596 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11715596 Country of ref document: EP Kind code of ref document: A2 |